The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women

Susan Davis; Penelope Robinson; Alain Moufarege; Robin Bell

doi:10.1111/j.1365-2265.2011.04301.x

The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women

Susan Davis
, Penelope Robinson
, Alain Moufarege
, Robin Bell

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

40 Citations (Scopus)

Abstract

Any form of screening aims to reduce disease specific and overall mortality and improve a person s future quality of life.

Original language	English
Pages (from-to)	541 - 547
Number of pages	7
Journal	Clinical Endocrinology
Volume	77
Issue number	4
DOIs	https://doi.org/10.1111/j.1365-2265.2011.04301.x
Publication status	Published - 2012

Access to Document

10.1111/j.1365-2265.2011.04301.x

Cite this

@article{34f86366395e4787b17c0495d97a85db,

title = "The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women",

abstract = "Any form of screening aims to reduce disease specific and overall mortality and improve a person s future quality of life.",

author = "Susan Davis and Penelope Robinson and Alain Moufarege and Robin Bell",

year = "2012",

doi = "10.1111/j.1365-2265.2011.04301.x",

language = "English",

volume = "77",

pages = "541 -- 547",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women

AU - Davis, Susan

AU - Robinson, Penelope

AU - Moufarege, Alain

AU - Bell, Robin

PY - 2012

Y1 - 2012

N2 - Any form of screening aims to reduce disease specific and overall mortality and improve a person s future quality of life.

AB - Any form of screening aims to reduce disease specific and overall mortality and improve a person s future quality of life.

UR - http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2265.2011.04301.x/pdf

U2 - 10.1111/j.1365-2265.2011.04301.x

DO - 10.1111/j.1365-2265.2011.04301.x

M3 - Article

SN - 0300-0664

VL - 77

SP - 541

EP - 547

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 4

ER -

The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women

Abstract

Access to Document

Other files and links

Cite this